ATE322488T1 - Stickstoffmonoxiddonoren, die auf metallischen zentren basieren - Google Patents

Stickstoffmonoxiddonoren, die auf metallischen zentren basieren

Info

Publication number
ATE322488T1
ATE322488T1 AT02718154T AT02718154T ATE322488T1 AT E322488 T1 ATE322488 T1 AT E322488T1 AT 02718154 T AT02718154 T AT 02718154T AT 02718154 T AT02718154 T AT 02718154T AT E322488 T1 ATE322488 T1 AT E322488T1
Authority
AT
Austria
Prior art keywords
sub
mrow
whole number
nonoate
aryl
Prior art date
Application number
AT02718154T
Other languages
English (en)
Inventor
Luigi Casella
Marina Ziche
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of ATE322488T1 publication Critical patent/ATE322488T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Glass Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02718154T 2001-03-01 2002-02-21 Stickstoffmonoxiddonoren, die auf metallischen zentren basieren ATE322488T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000426A ITMI20010426A1 (it) 2001-03-01 2001-03-01 Donatori di ossido di azoto basati su centri metallici

Publications (1)

Publication Number Publication Date
ATE322488T1 true ATE322488T1 (de) 2006-04-15

Family

ID=11447080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718154T ATE322488T1 (de) 2001-03-01 2002-02-21 Stickstoffmonoxiddonoren, die auf metallischen zentren basieren

Country Status (13)

Country Link
US (1) US6897218B2 (de)
EP (1) EP1370544B1 (de)
JP (1) JP2004518757A (de)
CN (1) CN1234698C (de)
AT (1) ATE322488T1 (de)
BR (1) BR0204465A (de)
DE (1) DE60210428T2 (de)
ES (1) ES2257538T3 (de)
HU (1) HUP0302262A2 (de)
IL (1) IL152555A0 (de)
IT (1) ITMI20010426A1 (de)
NO (1) NO324365B1 (de)
WO (1) WO2002070496A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
US7807624B2 (en) * 2006-01-11 2010-10-05 Affinergy, Inc. Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
US7531505B2 (en) * 2006-01-11 2009-05-12 Affinergy, Inc. Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
WO2007110084A1 (en) * 2006-03-27 2007-10-04 Salah Fathi Hussein Pyrazinic acid copper (i) complex
US20110136776A1 (en) * 2008-07-22 2011-06-09 Salah Fathiy Hussein Aly Ibraheim Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same
CA2771389C (en) 2009-08-21 2019-04-09 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
CN112266396B (zh) * 2020-10-10 2021-08-20 中国药科大学 一种基于生物正交化学的整合型前药、制备方法及其医药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5389675A (en) * 1992-03-27 1995-02-14 The United States Of America As Represented By The Department Of Health And Human Services Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
US5898038A (en) 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

Also Published As

Publication number Publication date
EP1370544A1 (de) 2003-12-17
US20040029854A1 (en) 2004-02-12
DE60210428D1 (de) 2006-05-18
WO2002070496A1 (en) 2002-09-12
ES2257538T3 (es) 2006-08-01
CN1458926A (zh) 2003-11-26
NO20025223D0 (no) 2002-10-31
EP1370544B1 (de) 2006-04-05
NO324365B1 (no) 2007-10-01
BR0204465A (pt) 2003-06-24
HUP0302262A2 (hu) 2003-10-28
CN1234698C (zh) 2006-01-04
JP2004518757A (ja) 2004-06-24
DE60210428T2 (de) 2006-11-23
NO20025223L (no) 2002-12-27
US6897218B2 (en) 2005-05-24
ITMI20010426A1 (it) 2002-09-01
IL152555A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
ATE322488T1 (de) Stickstoffmonoxiddonoren, die auf metallischen zentren basieren
Abdel‐Rahman et al. Three novel Ni (II), VO (II) and Cr (III) mononuclear complexes encompassing potentially tridentate imine ligand: Synthesis, structural characterization, DNA interaction, antimicrobial evaluation and anticancer activity
Hsieh et al. A turn-on Schiff base fluorescence sensor for zinc ion
Xu et al. A naphthalimide–calixarene as a two-faced and highly selective fluorescent chemosensor for Cu2+ or F−
Lee et al. Fluoride sensing with a PCT-based calix [4] arene
Kim et al. BODIPY appended cone-calix [4] arene: selective fluorescence changes upon Ca2+ binding
ES2129679T3 (es) Derivados que contienen el grupo amidino, utiles como inhibidores de la sintasa de oxido nitrico.
ATE203243T1 (de) Elektronenakzeptor-zusammensetzungen
DE69901451D1 (de) Ansa bis(.mu.-aluminium)-substituierte gruppe-4-metallkomplexe
IE45591L (en) Zinc alloy for galvanisation
DE60019638D1 (de) Katalysatorsysteme für polykondensationsreaktionen
PL354050A1 (en) 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays
TW200716518A (en) Acetylene derivatives
HUP9901065A2 (hu) Új barbitursavszármazékok, ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukra
DE60204784D1 (de) Lineare verbindungen enthaltend phenol und salicylsäure-einheiten
Paul et al. Metal-assisted unusual hydroxylation at the carbon atom of the triazine ring in dinuclear ruthenium (II) and osmium (II) complexes bridged by 2, 4, 6-tris (2-pyridyl)-1, 3, 5-triazine: Synthesis, structural characterization, stereochemistry, and electrochemical studies
Sathyaraj et al. Oxidative cleavage of DNA by ruthenium (II) complexes containing a ferrocene/non-ferrocene conjugated imidazole phenol ligand
Hilderbrand et al. Cobalt chemistry with mixed aminotroponiminate salicylaldiminate ligands: synthesis, characterization, and nitric oxide reactivity
Kumar et al. ‘On–Off’reversible switch for Fe3+ and F− mimicking XNOR logic function
DE60106277D1 (de) Katalysatoren
FI952597A0 (fi) Menetelmä muun kuin rautametallin, kuten kuparin tai nikkelin, muuttamiseksi happirikastuksella
ID23534A (id) Proses memproduksi katalis vanadium fosforus oksida
Santos et al. Transition metal complexes of two new imino-dihydroxamic acids
Ito et al. The reaction of 2′-deoxyribonucleoside with the α-pyrrolidonate-bridged Pt (III) dinuclear complex
TH1291B (th) กระบวนการและสารตัวกลางสำหรับการเตรียมไพริโด(๑,๔) เบนโซไดอาเซปปีน ที่ถูกแทนที่ด้วยอาริล

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties